Home506197 • BOM
add
Bliss GVS Pharma Ltd
Previous close
₹115.65
Day range
₹115.30 - ₹119.40
Year range
₹71.00 - ₹148.95
Market cap
12.22B INR
Avg Volume
44.23K
P/E ratio
14.08
Dividend yield
0.43%
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 2.01B | -2.43% |
Operating expense | 614.92M | 0.34% |
Net income | 276.10M | -1.19% |
Net profit margin | 13.76 | 1.33% |
Earnings per share | — | — |
EBITDA | 410.78M | -12.34% |
Effective tax rate | 27.40% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.63B | 12.07% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 9.63B | — |
Shares outstanding | 104.58M | — |
Price to book | 1.30 | — |
Return on assets | — | — |
Return on capital | 8.65% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 276.10M | -1.19% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Founded
1984
Website
Employees
763
